Correction to: Cell Death Discovery https://doi.org/10.1038/s41420-025-02300-7, published online 27 January 2025
In this article, the order of affiliations and numbering assigned to the authors was mistakenly misaligned. Furthermore, our school's English name has also been recently changed.
Yen-Han Tseng1,2,3,21, Trieu Thi My Tran4,5,21, Jinghua Tsai Chang6, Yu-Tang Huang4,7, Anh Thuc Nguyen4,8, Ian Yi‑Feng Chang8,9, Yi-Tung Chen8, Hao-Wen Hsieh10, Yue-Li Juang11, Peter Mu-Hsin Chang2,4,12,13, Tzu-Yi Huang3, Ying-Chih Chang14,15, Yuh-Min Chen1,2,*, Hsuan Liu7,16,17,18,** and Chi-Ying F. Huang4,19,20,***
1Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
2School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
3Program in Molecular Medicine, School of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
4Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
5Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
6Institute of Medicine, Chung Shan Medical University, Taichung City, Taiwan.
7Biomedical Industry Ph.D. Program, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
8Taiwan National Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
9Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
10Department of Neurosurgery, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
11Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
12Institute of Biomedical Sciences, Mackay Medical College, New Taipei City, Taiwan.
13Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
14Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.
15Department of Chemical Engineering, Stanford University, Stanford, CA, USA.
16Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
17Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
18Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
19Department of Biochemistry, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
20Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Should read:
Yen-Han Tseng1,2,3#, Trieu Thi My Tran4,5#, Jinghua Tsai Chang6, Yu-Tang Huang4,7, Anh Thuc Nguyen4,8, Ian Yi-Feng Chang9,10, Yi-Tung Chen9, Hao-Wen Hsieh11, Yue-Li Juang12, Peter Mu-Hsin Chang3,4,13, Tzu-Yi Huang2, Ying-Chih Chang14,15, Yuh-Min Chen1,3*, Hsuan Liu9,16,17,18*, Chi-Ying F. Huang4,19,20*
1Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
2Program in Molecular Medicine, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
3School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
4Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
5Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
6Institute of Medicine, Chung Shan Medical University, 110, Sec.1, Chien-Kuo N. Road, Taichung City 402306, Taiwan
7Biomedical Industry Ph.D. Program, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan
8Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan
9Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan
10Department of Neurosurgery, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
11Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
12Institute of Biomedical Sciences, Mackay Medical College, New Taipei City, Taiwan
13Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
14Acrocyte Therapeutics, Inc. 12-8F, 99, Xintai 5th Rd, Xizhi, New Taipei City, Taiwan
15Department of Chemical Engineering, Stanford University, Stanford, CA 94305
16Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan
17Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan
18Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
19Department of Biochemistry, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
20Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
#These authors contributed equally to this study.
*Corresponding authors
Yuh-Min Chen: email: ymchen@vghtpe.gov.tw ORCID: 0000-0003-0585-8463
Hsuan Liu: email: liu-hsuan@mail.cgu.edu.tw ORCID: 0000-0003-4691-2518
Chi-Ying F. Huang: email: cyhuang5@nycu.edu.tw ORCID: 0000-0003-4898-4937
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tseng, YH., Tran, T.T.M., Chang, J.T. et al. Correction: Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer. Cell Death Discov. 11, 199 (2025). https://doi.org/10.1038/s41420-025-02400-4
Published:
DOI: https://doi.org/10.1038/s41420-025-02400-4
